2020-2021: ABIOGENERATION: WE SUPPORT YOUR GENERATION’S BONES
Abiogen Pharma is here.
Abiogenerations is the claim of the 2020 corporate campaign. It underlines the experience that, for generations, has distinguished the Company in taking on, managing and supporting people with bone metabolism deseases.
Abiogen Pharma has been present for over five generations and by this campaign it confirms its commitment to the country and to italians, in every age of life.
2018-2019: WE SUPPORT THE RIGHT TO BONE HEALTH
A commitment that goes beyond drug development and production. By the 2018 corporate campaign, Abiogen sets itself as a reference of excellence in the prevention and treatment of osteoarticular pathologies, with a focus on osteoporosis by promoting a health policy activity centered on patient's health as primary aim. It is a support for the development and dissemination of information, aimed at facilitating patients' access to the correct treatments and their empowerment in adherence to therapy.
2017-2018: WE DO PREVENTION AND EVEN MORE
Abiogen is this too. The 2017 corporate campaign has two main targets: presenting the Company as a reference point and an excellence in the historical area of bone metabolism, with particular emphasis on the prevention and treatment of hypovitaminosis D, and focusing and awaking the attention of the target audience also in other therapeutic areas, such as dermatology and treatment of acute and chronic pain.
2015-2016: ACCESSIBLE: OUR IDEA OF DRUG
Our values, your health. “Our commitment is aimed at offering excellent and accessible solutions to improve everyone's quality of life”. This is the focus message that the 2015 corporate campaign aims to convey. Just like Abiogen's mission, by this campaign, we want to show the know-how of the company and its specialization, to develop, produce and market accessible therapeutic solutions in Italy and around the world, so that as many people as possible could get the benefit.